BCM
MDEV icon

Brasada Capital Management’s First Trust Indxx Medical Devices ETF MDEV Stock Holding History

Brasada Capital Management’s Portfolio MDEV Stock Details MDEV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,625
Closed -$255K – 156
2023
Q4 		$255K Buy
12,625
+712
+6% +$12.9K 0.05% 135
2023
Q3 		$211K Buy
11,913
+185
+2% +$3.65K 0.05% 119
2023
Q2 		$246K Buy
+11,728
New +$242K 0.05% 124

Other funds holding MDEV

GT
Glenview Trust Louisville, Kentucky $7.23B AUM 27.68% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Brasada Capital Management's MDEV Position: Q1 2024 in Review

Brasada Capital Management sold out of First Trust Indxx Medical Devices ETF (MDEV) in Q1 2024, closing a stake of 12,625 shares — an estimated $255K sold.

Brasada Capital Management first reported a position in MDEV in Q2 2023 and held it in 3 quarters. The position peaked at $255K in Q4 2023. 6 funds tracked by Wall St. Rank hold MDEV as of Q1 2024.

  • Brasada Capital Management reported no remaining First Trust Indxx Medical Devices ETF position as of Q1 2024 after selling out during the quarter.
  • Brasada Capital Management sold 12,625 First Trust Indxx Medical Devices ETF shares in Q1 2024, an estimated $255K.
  • Brasada Capital Management first reported a position in First Trust Indxx Medical Devices ETF in Q2 2023 and held it in 3 quarters.
  • Brasada Capital Management's First Trust Indxx Medical Devices ETF position peaked at $255K in Q4 2023.
  • 6 funds tracked by Wall St. Rank held First Trust Indxx Medical Devices ETF as of Q1 2024.

Based on Brasada Capital Management's 13F filing for Q1 2024, filed 15 May 2024.